Pharmafile Logo
Pharmafocus logo
Advanced Search
Merck image

Merck lines up early-stage Keytruda combo trial

April 1, 2015
Research and Development, Sales and Marketing Cancer, Merck, entinostat, keytruda, pd1, pembrolizumab, syndax

Merck is planning for Keytruda’s future by launching early-stage trials of the drug in combination with an investigational treatment from …

News
charles_mackay_pfizer

Pfizer appoints inflammation and immunology head

April 1, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Charles Reay Mackay, Pfizer

Professor Charles Reay Mackay is joining US pharma giant Pfizer as the chief scientific officer of its inflammation and immunology …

Appointment
Teva image

Teva bolsters neurology unit through Auspex deal

March 31, 2015
Sales and Marketing CNS, SD-809, Teva, Tourette syndrome, auspex, deutetrabenazine, neurology

Teva is significantly enhancing its neurology business by acquiring US biopharma firm Auspex in a deal worth $3.5 billion. Teva …

News
Novartis image

Novartis drug to treat iron overload gets US nod

March 31, 2015
Sales and Marketing FDA, Novartis, blood, deferasirox, exjade, iron, jadenu

Novartis’ iron overload drug Jadenu has been given the green light by US regulators to treat patients with a serious …

News
Pfizer image

Pfizer is pharma’s biggest advertiser

March 31, 2015
Medical Communications, Sales and Marketing AbbVie, AstraZeneca, Pfizer, advertising, adverts, dtc, lilly

US giant Pfizer spends far more on direct-to-consumer advertising than any other pharma firm according to new data from Kantar …

News
Merck Serono image

Merck Serono in $826m immuno-oncology deal

March 31, 2015
Research and Development, Sales and Marketing Intrexon, Merck, Merck Serono, T cell, biopharma, cart, immuno-oncology, t-cell

Merck Serono has announced a significant deal with Intrexon to develop and bring new cancer treatments to market. The German …

News
Genentech image

Roche subsidiary Genentech expands in manufacturing

March 31, 2015
Manufacturing and Production, Sales and Marketing Genentech, Roche, hillsboro, manufacturing, oregon

Californian drugmaker Genentech is planning a $125 million expansion at its Hillsboro manufacturing centre in Oregon. The Roche subsidiary plant …

News
john_bell

Immunocore appoints key scientist to board

March 31, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunocore, john bell

UK biotech Immunocore has appointed the Regius Professor of medicine at Oxford University and chairman of the office for the …

Appointment
Professor John Weinman image

Addressing the adherence gap

March 30, 2015
Research and Development, Sales and Marketing AstraZeneca, Kings College London, Professor John Weinman, adherence

Poor medication use in patients with long-term health conditions is widely recognised as a global problem that urgently needs to …

News

Novartis in major oncology drive

March 30, 2015
Research and Development, Sales and Marketing Cancer, FDA, MHRA, Novartis, aduro, ceritinib, eams, early access, zykadia

Novartis says it is ‘stepping up its efforts’ in cancer by launching major initiatives to discover new treatments to combat …

News
Google image

J&J and Google partner to build surgical robots

March 30, 2015
Medical Communications, Sales and Marketing Biogen, Ethicon, J&J, JJ, Johnson and Johnson, MS, google, robots

The medical device subsidiary of Johnson & Johnson Ethicon is to collaborate with Google to build surgical robots and perform …

News
GSK image

GSK and UK government agree meningitis B vaccine deal

March 30, 2015
Sales and Marketing AstraZeneca, Bexsero, GSK, Novartis, meningitis v, vaccines

The UK government has agreed a deal with GlaxoSmithKline to provide its meningitis B vaccine Bexsero on the NHS, after …

News
EMA image

EMA committee recommends five drugs for approval

March 30, 2015
Sales and Marketing Boehringer, CHMP, EMA, Eisai, Europe, Gardasil, Lenvima, Merck, akynzio, jardiance, lilly

Cancer and diabetes treatments are among those given the go ahead in the latest round of approvals by the EMA. …

News
abpi_and_nihr_conference_nov13

Funding boost for UK drugs manufacturing

March 30, 2015
Manufacturing and Production, Sales and Marketing ABPI, AstraZeneca, BIA, Bristol-Myers Squibb, Britest, Cambridge, Cambridge Crystallographic Data Centre, GlaxoSmithKline, Perceptive Engineering, Pfizer, Process Systems Enterprise, UCB, University of Leeds, amsci, mmip, stfc

The UK government is funding new manufacturing partnerships that will improve design processes and supply chain initiatives to lift the …

News
kamilla_rolsted

Bionor announces three new hires

March 30, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing barbara ruskin, bionor, kamilla rolsted, soren keller

Norwegian biotech Bionor has confirmed that three new members will be joining its executive management team. Dr Barbara Ruskin, senior …

Appointment
Orencia image

BMS backs rheumatoid arthritis prevention trial

March 27, 2015
Sales and Marketing BMS, Bristol-Myers Squibb, Orencia, RA, abatacept, rheumatoid arthritis

Bristol-Myers Squibb is funding a £3 million trial of Orencia as a preventative treatment for rheumatoid arthritis. The study will …

News
Novo image

Novo resubmits FDA application for two diabetes drugs

March 27, 2015
Sales and Marketing Danish, FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes

Novo Nordisk will re-submit an FDA application for its diabetes drugs Tresiba and Ryzodeg two years after their initial rejection …

News
Daiichi image

Daiichi Sankyo cuts 16% of US staff

March 27, 2015
Sales and Marketing Benicar, Daiichi Sankyo, FDA, Ranbaxy, Welchol, ambit, colesevelam, cuts, olmesartan

Daiichi Sankyo is laying off 16% of its staff at its US commercial headquarters as the company braces itself for …

News
Genome image

Big pharma teams with government on genomic research

March 27, 2015
Research and Development, Sales and Marketing AbbVie, Alexion Pharmaceuticals, AstraZeneca, Biogen, Cameron, Dimension Therapeutics, GSK, Genomic, Genomics england, Helomics, Roche, Takeda, UCB, UK, genomes

Ten firms will partner up with Genomics England to develop new diagnostics and treatments for people with rare diseases and …

News
terry_salyer

BioNano Genomics appoints chief commercial officer

March 27, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioNano Genomics, Terry Salyer

Genome mapping San Diego firm BioNano Genomics has appointed Terry Salyer as its chief commercial officer. Salyer has more than …

Appointment
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026